Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 2.81 is 52% below its 5-year average of 5.88, near the low end of its 5-year range (0.69–12.76).
As of the fiscal period ended Tuesday, June 30, 2026. 45.35% below its 12-month average of 5.15.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.81.
CURRENT RATIO
2.81
CURRENT RATIO AVG TTM
5.15
CURRENT RATIO AVG 3Y
4.51
CURRENT RATIO AVG 5Y
5.88
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-45.35%
CURRENT VS 3Y AVG
-37.57%
CURRENT VS 5Y AVG
-52.17%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.40
median of 621 covered companies
CURRENT VS SECTOR MEDIAN
-17.27%
vs the sector median at left
Dermata Therapeutics, Inc.
Market Cap
$4.55M
Current Ratio
2.81
TTM Avg
5.15
3Y Avg
4.51
5Y Avg
5.88
Market Cap
$4.43M
Current Ratio
1.57
TTM Avg
3.49
3Y Avg
6.45
5Y Avg
7.07
Market Cap
$4.79M
Current Ratio
10.60
TTM Avg
4.75
3Y Avg
13.42
5Y Avg
23.90
Market Cap
$4.83M
Current Ratio
8.63
TTM Avg
2.65
3Y Avg
2.36
5Y Avg
5.21
Market Cap
$5.01M
Current Ratio
1.88
TTM Avg
1.74
3Y Avg
1.99
5Y Avg
1.99
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Dermata Therapeutics, Inc. (DRMA) | $4.55M | 2.81 | 5.15 | 4.51 | 5.88 |
| CalciMedica, Inc. (CALC)vs › | $4.53M | 5.58 | 4.46 | 3.04 | 7.15 |
| CollPlant Biotechnologies Ltd. (CLGN)vs › | $4.43M | 1.57 | 3.49 | 6.45 | 7.07 |
| Lexaria Bioscience Corp. (LEXX)vs › | $4.79M | 10.60 | 4.75 | 13.42 | 23.90 |
| 20/20 Biolabs Inc. (AIDX)vs › | $4.28M | 1.99 | 1.05 | 3.08 | 3.15 |
| Bio Green Med Solution, Inc. (BGMS)vs › | $4.83M | 8.63 | 2.65 | 2.36 | 5.21 |
| GRI Bio, Inc. (GRI)vs › | $4.18M | 10.30 | 3.34 | 1.98 | 1.38 |
| Ernexa Therapeutics Inc. (ERNA)vs › | $3.97M | 2.01 | 0.91 | 1.26 | 1.78 |
| Basel Medical Group Ltd Ordinary Shares (BMGL)vs › | $5.01M | 1.88 | 1.74 | 1.99 | 1.99 |
| Aptevo Therapeutics Inc. (APVO)vs › | $4.00M | 2.08 | 2.77 | 2.83 | 2.68 |
Current Ratio
2.81
Quick Ratio
2.73
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 2.81 |
| 2026-03-31 | 7.09 |
| 2025-12-31 | 4.79 |
| 2025-09-30 | 4.56 |
| 2025-06-30 | 6.47 |
| 2025-03-31 | 3.70 |
| 2024-12-31 | 1.79 |
| 2024-09-30 | 3.44 |
| 2024-06-30 | 2.73 |
| 2024-03-31 | 3.78 |
| 2023-12-31 | 4.91 |
| 2023-09-30 | 7.99 |
| 2023-06-30 | 12.76 |
| 2023-03-31 | 7.70 |
| 2022-12-31 | 7.53 |
| 2022-09-30 | 5.97 |
| 2022-06-30 | 8.07 |
| 2022-03-31 | 7.59 |
| 2021-12-31 | 7.66 |
| 2021-09-30 | 11.45 |
| 2021-06-30 | 0.69 |
| 2021-03-31 | 1.76 |
| 2020-12-31 | 0.16 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
